Why you need Drug Delivery - Innovations, trends, and their impact on pharma
Revolutionary changes are disrupting the status quo simply through developments in the way drugs are given to patients. In a rapidly evolving field, drug delivery systems are offering growth opportunities and solutions – as well as presenting difficulties – as the range of choices grows.
To make sure you don't get left behind you need to understand what is happening at the cutting edge from experts innovating and leading the way through the technological and regulatory minefield. See how companies like Sanofi, Surefire Medical and Invion among other market leaders explain how they see the market and how they are dealing with the challenges.
Key Issues Explored
Who needs this report?
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.
Table of Contents
for Drug Delivery - Innovations, trends, and their impact on pharma [Published by FirstWord Pharma]
|Title||Date Published||Price from||More Details|
| Orphan Drug Commercialisation and Market Access in Emerging Markets|
IntroductionMarket access for orphan drugs: Can your company break through in emerging markets?Find ...
|01 Jul 2016 by FirstWord Pharma||USD $591 (normally
| Orphan Drug Commercial Models: Sustaining the rare disease business|
IntroductionChoosing the right commercial model for orphan drug successThe societal and commercial a...
|01 May 2016 by FirstWord Pharma||USD $591 (normally
| Pay-for-Performance and Drug Pricing: Impact and Response of Pharma |
IntroductionThe pay for performance agenda gathers pace as US payers rebel the cost of drugs.Pharma ...
|01 Mar 2016 by FirstWord Pharma||USD $591 (normally
| Innovations in Drug Pricing and Reimbursement (2016)|
IntroductionIs the drug pricing bubble about to burst?Drug costs are becoming unaffordable and draco...
|01 Feb 2016 by FirstWord Pharma||USD $1,866 (normally
| Physician Views: Which companies excel in diabetes drug marketing and why?|
Scope With both the insulin and non-insulin segments of the diabetes market expected to become more ...
|01 May 2015 by FirstWord Pharma||USD $591 (normally
| Trends and Innovations in Drug Pricing|
IntroductionFirstWord’s Trends and Innovations in Drug Pricing report dissects international trends ...
|01 Jan 2015 by FirstWord Pharma||USD $591 (normally
| Orphan Drug Market Access: Payer Insights on the Present and Future|
IntroductionOrphan Drug Market Access: Payer Insights on the Present and Future is a report that exa...
|14 Oct 2014 by FirstWord Pharma||USD $591 (normally
| Physician Views: With drug developers on the brink of Phase III for NASH, how large is the actual market opportunity?|
Scope While no drugs are approved for non-alcoholic steatohepatitis (NASH), at least eight agents ha...
|04 Aug 2014 by FirstWord Pharma||USD $591 (normally
| Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?|
ScopeSales of Biogen Idec’s multiple sclerosis therapy Tecfidera may continue to exceed initial expe...
|01 Nov 2013 by FirstWord Pharma||USD $591 (normally
| Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class|
ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
|01 Jun 2013 by FirstWord Pharma||USD $591 (normally
This report is published by FirstWord Pharma
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.